Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other 1

Conditions

Breast Neoplasms 18Prostatic Neoplasms 16Colorectal Neoplasms 14Neoplasms 12Hematopoietic and Lymphatic System Neoplasm 12Lung Neoplasms 9Hematologic Neoplasms 8Ovarian Neoplasms 5Multiple Myeloma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Malignant Solid Neoplasm 4Lymphoma 4Urinary Bladder Neoplasms 3Hematopoietic and Lymphoid System Neoplasm 3Endometrial Neoplasms 3Advanced Malignant Solid Neoplasm 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Thyroid Cancer, Papillary 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Obesity-Related Malignant Neoplasm 2Mouth Neoplasms 2Motor Activity 2Melanoma 2Malignant Female Reproductive System Neoplasm 2Leukemia, Myeloid, Acute 2Leukemia 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2

Interventions

Standard of Care 1Spinal Cord Stimulation 1Specimen Handling 1Practice Guidelines as Topic 1Methods 1Massage 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chemotherapy-Induced Peripheral Neuropathy × Interviews as Topic × 1 year × Clear all
NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡